Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 71 | 2024 | 2921 | 7.260 |
Why?
|
Tongue Neoplasms | 13 | 2023 | 187 | 6.870 |
Why?
|
Mouth Neoplasms | 23 | 2024 | 594 | 6.700 |
Why?
|
Carcinoma, Squamous Cell | 46 | 2024 | 4046 | 4.610 |
Why?
|
Otolaryngology | 17 | 2024 | 698 | 2.690 |
Why?
|
Tongue | 13 | 2023 | 405 | 2.680 |
Why?
|
Oropharyngeal Neoplasms | 11 | 2022 | 492 | 2.020 |
Why?
|
Papillomavirus Infections | 14 | 2022 | 1637 | 1.730 |
Why?
|
Lingual Nerve | 3 | 2019 | 31 | 1.690 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 8 | 2021 | 325 | 1.630 |
Why?
|
Glossectomy | 7 | 2023 | 60 | 1.500 |
Why?
|
Salivary Gland Neoplasms | 3 | 2020 | 305 | 1.480 |
Why?
|
Surgical Flaps | 16 | 2021 | 1678 | 1.340 |
Why?
|
Oral Surgical Procedures | 2 | 2021 | 172 | 1.200 |
Why?
|
Deglutition Disorders | 5 | 2023 | 640 | 1.080 |
Why?
|
Papillomaviridae | 7 | 2022 | 1137 | 0.960 |
Why?
|
Mouth | 4 | 2021 | 382 | 0.950 |
Why?
|
Hypoglossal Nerve | 2 | 2016 | 110 | 0.930 |
Why?
|
Free Tissue Flaps | 5 | 2024 | 335 | 0.920 |
Why?
|
Tracheal Stenosis | 2 | 2017 | 227 | 0.900 |
Why?
|
Ultrasonography | 7 | 2023 | 5997 | 0.830 |
Why?
|
Neck Dissection | 4 | 2019 | 201 | 0.790 |
Why?
|
Laryngeal Neoplasms | 4 | 2018 | 513 | 0.770 |
Why?
|
Cross Infection | 2 | 2020 | 1427 | 0.720 |
Why?
|
Neoplasm Staging | 16 | 2024 | 11208 | 0.720 |
Why?
|
Larynx, Artificial | 2 | 2020 | 70 | 0.720 |
Why?
|
Hematology | 1 | 2024 | 243 | 0.710 |
Why?
|
Alphapapillomavirus | 3 | 2022 | 219 | 0.710 |
Why?
|
Humans | 202 | 2024 | 766011 | 0.710 |
Why?
|
Laryngoplasty | 1 | 2020 | 53 | 0.690 |
Why?
|
Marital Status | 2 | 2019 | 426 | 0.690 |
Why?
|
Speech Disorders | 1 | 2021 | 178 | 0.670 |
Why?
|
Ranula | 1 | 2019 | 10 | 0.650 |
Why?
|
Papillomavirus Vaccines | 4 | 2022 | 495 | 0.650 |
Why?
|
Tracheostomy | 2 | 2020 | 429 | 0.640 |
Why?
|
Retrospective Studies | 61 | 2024 | 81522 | 0.640 |
Why?
|
Salivary Glands | 1 | 2020 | 231 | 0.630 |
Why?
|
Survivors | 4 | 2018 | 2374 | 0.630 |
Why?
|
Marketing of Health Services | 1 | 2020 | 151 | 0.630 |
Why?
|
Sexual Behavior | 3 | 2019 | 2192 | 0.620 |
Why?
|
Deglutition | 4 | 2023 | 208 | 0.610 |
Why?
|
Reimbursement, Incentive | 3 | 2020 | 541 | 0.610 |
Why?
|
Patient Care | 1 | 2024 | 629 | 0.610 |
Why?
|
Scalp | 4 | 2016 | 388 | 0.580 |
Why?
|
Cost Control | 1 | 2020 | 625 | 0.570 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.560 |
Why?
|
Insurance Coverage | 5 | 2020 | 1946 | 0.550 |
Why?
|
Patient Advocacy | 1 | 2019 | 361 | 0.550 |
Why?
|
Tracheotomy | 1 | 2018 | 174 | 0.550 |
Why?
|
State Government | 1 | 2020 | 388 | 0.550 |
Why?
|
Access to Information | 1 | 2020 | 317 | 0.550 |
Why?
|
SEER Program | 10 | 2022 | 1444 | 0.540 |
Why?
|
Medicare | 9 | 2023 | 6821 | 0.540 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 588 | 0.530 |
Why?
|
Mouth Mucosa | 2 | 2018 | 432 | 0.520 |
Why?
|
Lip | 3 | 2023 | 195 | 0.510 |
Why?
|
Orbit | 3 | 2006 | 458 | 0.500 |
Why?
|
Nose Neoplasms | 4 | 2021 | 249 | 0.500 |
Why?
|
Postoperative Complications | 10 | 2024 | 15803 | 0.490 |
Why?
|
Oropharynx | 1 | 2016 | 140 | 0.490 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3836 | 0.480 |
Why?
|
Male | 99 | 2024 | 363808 | 0.480 |
Why?
|
Cytodiagnosis | 1 | 2019 | 450 | 0.480 |
Why?
|
Temporal Bone | 5 | 2008 | 683 | 0.480 |
Why?
|
Middle Aged | 83 | 2024 | 223058 | 0.480 |
Why?
|
Aged | 69 | 2023 | 171233 | 0.470 |
Why?
|
Conflict of Interest | 1 | 2019 | 556 | 0.460 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 388 | 0.450 |
Why?
|
Salvage Therapy | 4 | 2021 | 1272 | 0.450 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3099 | 0.450 |
Why?
|
Cross-Sectional Studies | 17 | 2023 | 26283 | 0.450 |
Why?
|
Mandible | 2 | 2014 | 746 | 0.450 |
Why?
|
Quality of Life | 10 | 2023 | 13470 | 0.450 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3222 | 0.450 |
Why?
|
Health Status Disparities | 2 | 2015 | 1880 | 0.440 |
Why?
|
United States | 38 | 2024 | 72914 | 0.440 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1130 | 0.440 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 994 | 0.440 |
Why?
|
Myoblasts | 2 | 2006 | 234 | 0.440 |
Why?
|
Laryngectomy | 6 | 2023 | 245 | 0.430 |
Why?
|
Pain, Postoperative | 2 | 2021 | 1773 | 0.430 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 939 | 0.430 |
Why?
|
Female | 94 | 2024 | 396159 | 0.430 |
Why?
|
Neoplasms | 9 | 2024 | 22350 | 0.430 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2023 | 9371 | 0.410 |
Why?
|
Drug Industry | 1 | 2019 | 791 | 0.410 |
Why?
|
Thyroid Cartilage | 4 | 2004 | 46 | 0.410 |
Why?
|
Medical Oncology | 1 | 2024 | 2340 | 0.400 |
Why?
|
Cause of Death | 3 | 2018 | 3710 | 0.390 |
Why?
|
Microsurgery | 3 | 2009 | 798 | 0.390 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2006 | 354 | 0.380 |
Why?
|
Jugular Veins | 2 | 2021 | 211 | 0.380 |
Why?
|
Inpatients | 2 | 2022 | 2565 | 0.370 |
Why?
|
Craniotomy | 1 | 2016 | 731 | 0.370 |
Why?
|
Skull | 1 | 2016 | 814 | 0.370 |
Why?
|
Pandemics | 4 | 2023 | 8699 | 0.360 |
Why?
|
Ear Neoplasms | 3 | 2008 | 118 | 0.360 |
Why?
|
Medicaid | 4 | 2020 | 2832 | 0.360 |
Why?
|
Physician-Patient Relations | 1 | 2024 | 3278 | 0.360 |
Why?
|
Survival Analysis | 8 | 2018 | 10086 | 0.350 |
Why?
|
Awareness | 1 | 2015 | 653 | 0.350 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2780 | 0.350 |
Why?
|
Neoplasm Invasiveness | 8 | 2023 | 3599 | 0.350 |
Why?
|
Life Expectancy | 1 | 2017 | 1249 | 0.340 |
Why?
|
Anemia | 2 | 2019 | 1511 | 0.340 |
Why?
|
Trachea | 2 | 2015 | 1086 | 0.340 |
Why?
|
Frozen Sections | 3 | 2020 | 152 | 0.340 |
Why?
|
Prognosis | 13 | 2023 | 29915 | 0.330 |
Why?
|
Neoplasms, Second Primary | 2 | 2018 | 1056 | 0.330 |
Why?
|
Skull Base Neoplasms | 3 | 2008 | 276 | 0.320 |
Why?
|
Disease-Free Survival | 8 | 2019 | 6838 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2022 | 4057 | 0.310 |
Why?
|
Carcinoma, Adenoid Cystic | 5 | 2022 | 261 | 0.310 |
Why?
|
Adult | 54 | 2021 | 223109 | 0.310 |
Why?
|
Preoperative Care | 1 | 2018 | 2277 | 0.310 |
Why?
|
Facial Nerve | 2 | 2023 | 277 | 0.310 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1663 | 0.310 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1545 | 0.300 |
Why?
|
Pilot Projects | 5 | 2023 | 8733 | 0.300 |
Why?
|
Aged, 80 and over | 29 | 2022 | 59526 | 0.300 |
Why?
|
Societies, Medical | 1 | 2019 | 3954 | 0.280 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2021 | 243 | 0.280 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2008 | 96 | 0.280 |
Why?
|
Bone Marrow Cells | 1 | 2014 | 2412 | 0.280 |
Why?
|
Radiotherapy, Adjuvant | 7 | 2023 | 1776 | 0.270 |
Why?
|
Laryngostenosis | 2 | 2010 | 168 | 0.270 |
Why?
|
Stents | 2 | 2017 | 3236 | 0.260 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2177 | 0.260 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 2354 | 0.260 |
Why?
|
Internship and Residency | 4 | 2022 | 5947 | 0.260 |
Why?
|
Speech | 2 | 2021 | 556 | 0.260 |
Why?
|
Patient Protection and Affordable Care Act | 3 | 2020 | 1188 | 0.250 |
Why?
|
Nasal Cavity | 4 | 2021 | 309 | 0.250 |
Why?
|
Skin Neoplasms | 5 | 2023 | 5838 | 0.240 |
Why?
|
Forearm | 5 | 2023 | 427 | 0.230 |
Why?
|
Sex Factors | 6 | 2019 | 10605 | 0.230 |
Why?
|
Orbital Diseases | 1 | 2006 | 178 | 0.230 |
Why?
|
Treatment Outcome | 19 | 2023 | 65236 | 0.230 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4041 | 0.230 |
Why?
|
Microcirculation | 1 | 2009 | 1279 | 0.230 |
Why?
|
Orbit Evisceration | 1 | 2003 | 9 | 0.220 |
Why?
|
Sensation | 2 | 2023 | 331 | 0.220 |
Why?
|
Speech Intelligibility | 2 | 2023 | 80 | 0.220 |
Why?
|
Reimbursement Mechanisms | 2 | 2020 | 672 | 0.220 |
Why?
|
Intensive Care Units | 1 | 2017 | 3803 | 0.220 |
Why?
|
Coloring Agents | 2 | 2021 | 562 | 0.210 |
Why?
|
Rectus Abdominis | 1 | 2003 | 101 | 0.210 |
Why?
|
Carcinoma, Basal Cell | 5 | 2008 | 565 | 0.210 |
Why?
|
Laryngeal Diseases | 2 | 2020 | 248 | 0.200 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 3 | 2013 | 353 | 0.200 |
Why?
|
Depressive Disorder, Major | 2 | 2019 | 4813 | 0.200 |
Why?
|
Phonation | 2 | 2020 | 221 | 0.200 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2564 | 0.200 |
Why?
|
Fistula | 3 | 2012 | 212 | 0.200 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 196 | 0.190 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5368 | 0.190 |
Why?
|
Adenocarcinoma | 3 | 2018 | 6361 | 0.190 |
Why?
|
Rats, Wistar | 2 | 2016 | 1884 | 0.190 |
Why?
|
Fascia | 2 | 2000 | 143 | 0.190 |
Why?
|
Indocyanine Green | 1 | 2023 | 233 | 0.190 |
Why?
|
Facial Neoplasms | 2 | 2002 | 126 | 0.190 |
Why?
|
Communication | 1 | 2016 | 3913 | 0.190 |
Why?
|
Prostheses and Implants | 3 | 2000 | 1273 | 0.180 |
Why?
|
Logistic Models | 5 | 2020 | 13271 | 0.180 |
Why?
|
Reoperation | 4 | 2018 | 4310 | 0.180 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7838 | 0.180 |
Why?
|
Smoking | 2 | 2017 | 9082 | 0.180 |
Why?
|
Eye Diseases | 1 | 2006 | 660 | 0.180 |
Why?
|
Cricoid Cartilage | 2 | 2015 | 69 | 0.180 |
Why?
|
Cohort Studies | 12 | 2024 | 41652 | 0.180 |
Why?
|
Postoperative Care | 3 | 2020 | 1475 | 0.180 |
Why?
|
Intraoperative Period | 2 | 2021 | 511 | 0.180 |
Why?
|
Risk Assessment | 6 | 2021 | 24299 | 0.180 |
Why?
|
Parotid Neoplasms | 2 | 2019 | 157 | 0.180 |
Why?
|
Pharyngectomy | 1 | 2000 | 45 | 0.180 |
Why?
|
Endocrine Surgical Procedures | 1 | 2020 | 32 | 0.170 |
Why?
|
Preoperative Period | 2 | 2021 | 567 | 0.170 |
Why?
|
Neoplasm Metastasis | 4 | 2019 | 4884 | 0.170 |
Why?
|
Relative Value Scales | 1 | 2020 | 85 | 0.170 |
Why?
|
Adenoviruses, Human | 2 | 2014 | 258 | 0.170 |
Why?
|
Fee Schedules | 1 | 2020 | 86 | 0.170 |
Why?
|
Intubation | 1 | 2000 | 141 | 0.170 |
Why?
|
Positron-Emission Tomography | 2 | 2013 | 6545 | 0.170 |
Why?
|
Epistaxis | 1 | 2000 | 119 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2015 | 4638 | 0.160 |
Why?
|
Nose | 2 | 2020 | 518 | 0.160 |
Why?
|
Skull Neoplasms | 2 | 2007 | 173 | 0.160 |
Why?
|
Sphenoid Bone | 1 | 2000 | 176 | 0.160 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12060 | 0.160 |
Why?
|
Insurance, Health | 4 | 2020 | 2521 | 0.160 |
Why?
|
Toll-Like Receptor 8 | 3 | 2014 | 98 | 0.160 |
Why?
|
Young Adult | 13 | 2021 | 59870 | 0.160 |
Why?
|
Prospective Payment System | 1 | 2020 | 135 | 0.160 |
Why?
|
Mandibular Neoplasms | 1 | 2000 | 131 | 0.160 |
Why?
|
Economics, Hospital | 1 | 2021 | 208 | 0.160 |
Why?
|
Illinois | 1 | 2019 | 120 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 6 | 2021 | 20676 | 0.150 |
Why?
|
Research Report | 1 | 2022 | 367 | 0.150 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 91 | 0.150 |
Why?
|
Prospective Studies | 9 | 2023 | 54818 | 0.150 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2015 | 1104 | 0.150 |
Why?
|
Phototherapy | 1 | 2021 | 369 | 0.150 |
Why?
|
Managed Competition | 1 | 2018 | 33 | 0.150 |
Why?
|
Case-Control Studies | 6 | 2023 | 22230 | 0.150 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2017 | 17 | 0.150 |
Why?
|
Carotid Artery, Common | 2 | 2009 | 173 | 0.150 |
Why?
|
Dissection | 2 | 2019 | 299 | 0.150 |
Why?
|
Immune System Phenomena | 1 | 2017 | 17 | 0.150 |
Why?
|
Momordica charantia | 1 | 2017 | 8 | 0.150 |
Why?
|
Regression Analysis | 3 | 2017 | 6321 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2015 | 4404 | 0.150 |
Why?
|
Nasal Mucosa | 1 | 2021 | 416 | 0.140 |
Why?
|
Models, Educational | 1 | 2020 | 376 | 0.140 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 215 | 0.140 |
Why?
|
Arteries | 1 | 2022 | 1123 | 0.140 |
Why?
|
Skin Transplantation | 2 | 2000 | 1098 | 0.140 |
Why?
|
Fluorescent Dyes | 2 | 2023 | 1922 | 0.140 |
Why?
|
Hematocrit | 1 | 2019 | 622 | 0.140 |
Why?
|
Carotid Artery, Internal | 1 | 2000 | 442 | 0.140 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 394 | 0.140 |
Why?
|
Vocal Cord Paralysis | 3 | 2000 | 275 | 0.140 |
Why?
|
Medically Uninsured | 2 | 2020 | 838 | 0.140 |
Why?
|
Aerosols | 1 | 2020 | 632 | 0.140 |
Why?
|
Financing, Government | 1 | 2021 | 473 | 0.140 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 116 | 0.140 |
Why?
|
Specialties, Surgical | 1 | 2022 | 391 | 0.140 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 17060 | 0.140 |
Why?
|
Regeneration | 1 | 2006 | 1517 | 0.140 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2022 | 453 | 0.140 |
Why?
|
Suicide | 2 | 2018 | 1606 | 0.140 |
Why?
|
Odds Ratio | 3 | 2019 | 9654 | 0.140 |
Why?
|
Survival Rate | 9 | 2021 | 12821 | 0.140 |
Why?
|
Cutaneous Fistula | 2 | 2012 | 80 | 0.140 |
Why?
|
Immunization Schedule | 1 | 2018 | 229 | 0.140 |
Why?
|
Adenoidectomy | 1 | 2018 | 171 | 0.140 |
Why?
|
Age Factors | 4 | 2018 | 18384 | 0.140 |
Why?
|
Face | 2 | 2002 | 1028 | 0.130 |
Why?
|
Physician Incentive Plans | 1 | 2018 | 165 | 0.130 |
Why?
|
Dentigerous Cyst | 1 | 1996 | 18 | 0.130 |
Why?
|
Maxillary Diseases | 1 | 1996 | 46 | 0.130 |
Why?
|
Plant Extracts | 2 | 2017 | 498 | 0.130 |
Why?
|
Esophagectomy | 1 | 2000 | 477 | 0.130 |
Why?
|
Liver Function Tests | 1 | 2018 | 527 | 0.130 |
Why?
|
Biopsy | 5 | 2024 | 6766 | 0.130 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 434 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2013 | 2025 | 0.130 |
Why?
|
Granuloma, Laryngeal | 1 | 1995 | 7 | 0.130 |
Why?
|
Tonsillar Neoplasms | 1 | 1996 | 49 | 0.130 |
Why?
|
Vaccination | 2 | 2018 | 3425 | 0.130 |
Why?
|
Adolescent | 19 | 2020 | 88804 | 0.130 |
Why?
|
Rats | 5 | 2016 | 23702 | 0.120 |
Why?
|
Lymphatic Metastasis | 2 | 2022 | 2883 | 0.120 |
Why?
|
Mastication | 1 | 2015 | 53 | 0.120 |
Why?
|
Kidney Function Tests | 1 | 2018 | 685 | 0.120 |
Why?
|
Neck Muscles | 1 | 2015 | 100 | 0.120 |
Why?
|
Reference Standards | 1 | 2019 | 1013 | 0.120 |
Why?
|
Paranasal Sinus Diseases | 2 | 2012 | 121 | 0.120 |
Why?
|
Databases, Factual | 5 | 2019 | 8062 | 0.120 |
Why?
|
Granuloma, Foreign-Body | 1 | 1995 | 41 | 0.120 |
Why?
|
Medicine | 1 | 2023 | 943 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.120 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2015 | 169 | 0.120 |
Why?
|
Tonsillectomy | 1 | 2018 | 284 | 0.120 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2013 | 3110 | 0.120 |
Why?
|
Thigh | 1 | 2016 | 237 | 0.120 |
Why?
|
Wrist | 1 | 1996 | 230 | 0.120 |
Why?
|
Office Visits | 1 | 2019 | 594 | 0.120 |
Why?
|
Rats, Inbred Lew | 3 | 2006 | 1167 | 0.120 |
Why?
|
Laryngeal Nerves | 1 | 1994 | 57 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 540 | 0.120 |
Why?
|
Pharyngeal Muscles | 1 | 1994 | 81 | 0.110 |
Why?
|
Polytetrafluoroethylene | 1 | 1995 | 242 | 0.110 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12520 | 0.110 |
Why?
|
Cucurbitaceae | 1 | 2013 | 2 | 0.110 |
Why?
|
Spiral Ganglion | 1 | 2015 | 180 | 0.110 |
Why?
|
Carotid Artery Diseases | 1 | 2000 | 878 | 0.110 |
Why?
|
Sexual Partners | 1 | 2019 | 804 | 0.110 |
Why?
|
Hospitals, University | 1 | 2015 | 574 | 0.110 |
Why?
|
Prosthesis Design | 1 | 2020 | 2112 | 0.110 |
Why?
|
Physicians | 2 | 2022 | 4587 | 0.110 |
Why?
|
Down-Regulation | 3 | 2018 | 2925 | 0.110 |
Why?
|
Betapapillomavirus | 1 | 2013 | 14 | 0.110 |
Why?
|
Hand Strength | 1 | 1996 | 462 | 0.110 |
Why?
|
Incidence | 4 | 2019 | 21507 | 0.110 |
Why?
|
Internationality | 1 | 2019 | 1006 | 0.110 |
Why?
|
Adenovirus E1A Proteins | 1 | 2013 | 81 | 0.110 |
Why?
|
Vascular Surgical Procedures | 1 | 2002 | 1516 | 0.110 |
Why?
|
Paralysis | 1 | 1994 | 248 | 0.110 |
Why?
|
Prevalence | 3 | 2019 | 15833 | 0.100 |
Why?
|
Independent Living | 1 | 2017 | 585 | 0.100 |
Why?
|
Neck | 4 | 2021 | 734 | 0.100 |
Why?
|
Parotid Gland | 3 | 2023 | 177 | 0.100 |
Why?
|
Lymphoma | 1 | 2002 | 1897 | 0.100 |
Why?
|
Cranial Irradiation | 1 | 2015 | 384 | 0.100 |
Why?
|
Risk-Taking | 1 | 2018 | 1021 | 0.100 |
Why?
|
Chondroblastoma | 1 | 1992 | 47 | 0.100 |
Why?
|
Bone Resorption | 1 | 1996 | 717 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 452 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15403 | 0.100 |
Why?
|
Tumor Microenvironment | 5 | 2017 | 3947 | 0.100 |
Why?
|
Health Care Reform | 1 | 2021 | 1259 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1135 | 0.090 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3414 | 0.090 |
Why?
|
Oncogene Proteins, Viral | 1 | 2013 | 341 | 0.090 |
Why?
|
Incidental Findings | 3 | 2011 | 696 | 0.090 |
Why?
|
Neurosurgical Procedures | 1 | 2002 | 2082 | 0.090 |
Why?
|
Oncolytic Virotherapy | 2 | 2014 | 520 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3431 | 0.090 |
Why?
|
Animals | 19 | 2024 | 168721 | 0.090 |
Why?
|
Motivation | 1 | 2020 | 2020 | 0.090 |
Why?
|
Coculture Techniques | 4 | 2018 | 1336 | 0.090 |
Why?
|
Transcription Factors | 2 | 2022 | 12123 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2000 | 1272 | 0.090 |
Why?
|
Fluorescence | 2 | 2023 | 752 | 0.090 |
Why?
|
Time Factors | 5 | 2021 | 40117 | 0.090 |
Why?
|
Tissue Engineering | 3 | 2006 | 1855 | 0.090 |
Why?
|
Combined Modality Therapy | 4 | 2021 | 8531 | 0.090 |
Why?
|
Mice, SCID | 4 | 2017 | 2627 | 0.080 |
Why?
|
Cannabis | 1 | 2016 | 446 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 616 | 0.080 |
Why?
|
Hospitalization | 2 | 2020 | 10807 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 561 | 0.080 |
Why?
|
Registries | 3 | 2020 | 8321 | 0.080 |
Why?
|
Anastomosis, Surgical | 2 | 2021 | 992 | 0.080 |
Why?
|
Students, Medical | 1 | 2022 | 1959 | 0.080 |
Why?
|
Length of Stay | 2 | 2021 | 6492 | 0.080 |
Why?
|
Risk | 2 | 2020 | 9600 | 0.080 |
Why?
|
Health Expenditures | 2 | 2019 | 2386 | 0.080 |
Why?
|
Cochlea | 1 | 2015 | 847 | 0.080 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18289 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2418 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2020 | 3538 | 0.080 |
Why?
|
Risk Factors | 10 | 2020 | 74870 | 0.080 |
Why?
|
Constriction, Pathologic | 2 | 2023 | 1108 | 0.080 |
Why?
|
Cadaver | 3 | 2020 | 1362 | 0.080 |
Why?
|
Ear Auricle | 1 | 2008 | 31 | 0.080 |
Why?
|
Missouri | 1 | 2008 | 112 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 2 | 2015 | 1811 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 1996 | 1383 | 0.070 |
Why?
|
Patient Discharge | 1 | 2021 | 3466 | 0.070 |
Why?
|
Adaptive Immunity | 1 | 2013 | 733 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2415 | 0.070 |
Why?
|
Subclavian Artery | 1 | 2008 | 137 | 0.070 |
Why?
|
DNA, Viral | 3 | 2022 | 2200 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5782 | 0.070 |
Why?
|
Pneumonia | 1 | 2019 | 2156 | 0.070 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39226 | 0.070 |
Why?
|
Radiotherapy | 4 | 2021 | 1494 | 0.070 |
Why?
|
Maxillary Sinus | 2 | 2000 | 172 | 0.070 |
Why?
|
Cell Proliferation | 5 | 2024 | 10429 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2015 | 1352 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1108 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2017 | 5304 | 0.070 |
Why?
|
Nursing Staff, Hospital | 1 | 2009 | 350 | 0.060 |
Why?
|
Breast Neoplasms | 4 | 2015 | 21062 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2008 | 308 | 0.060 |
Why?
|
Carbon | 2 | 2006 | 676 | 0.060 |
Why?
|
Mice, Inbred NOD | 3 | 2015 | 1837 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1489 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3106 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3854 | 0.060 |
Why?
|
Treatment Failure | 1 | 2011 | 2654 | 0.060 |
Why?
|
Ear, External | 3 | 2007 | 164 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3457 | 0.060 |
Why?
|
Head | 2 | 2005 | 925 | 0.060 |
Why?
|
Critical Care | 1 | 2017 | 2712 | 0.060 |
Why?
|
Mice | 11 | 2024 | 81786 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3230 | 0.060 |
Why?
|
Mice, Nude | 2 | 2024 | 3613 | 0.060 |
Why?
|
Melanoma | 3 | 2021 | 5696 | 0.050 |
Why?
|
Immunity, Innate | 2 | 2013 | 3078 | 0.050 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 750 | 0.050 |
Why?
|
Radiotherapy Dosage | 3 | 2018 | 2864 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2839 | 0.050 |
Why?
|
Depression | 2 | 2023 | 8237 | 0.050 |
Why?
|
Hematoma | 2 | 2005 | 766 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1409 | 0.050 |
Why?
|
Smiling | 1 | 2023 | 71 | 0.050 |
Why?
|
Facial Muscles | 1 | 2023 | 159 | 0.050 |
Why?
|
Dilatation | 1 | 2023 | 311 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5508 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1796 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2013 | 2746 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2014 | 3606 | 0.050 |
Why?
|
Apoptosis | 4 | 2024 | 9511 | 0.050 |
Why?
|
Fibula | 1 | 2024 | 270 | 0.050 |
Why?
|
Orbital Neoplasms | 1 | 2003 | 222 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14645 | 0.050 |
Why?
|
Decompression, Surgical | 1 | 2006 | 603 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3237 | 0.050 |
Why?
|
Saphenous Vein | 1 | 2004 | 520 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2024 | 529 | 0.050 |
Why?
|
Educational Status | 2 | 2019 | 2513 | 0.050 |
Why?
|
Titanium | 1 | 2004 | 490 | 0.050 |
Why?
|
Immunohistochemistry | 4 | 2019 | 11036 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20125 | 0.050 |
Why?
|
Signal Transduction | 4 | 2024 | 23590 | 0.050 |
Why?
|
Graft Survival | 2 | 2005 | 3897 | 0.050 |
Why?
|
Speech, Esophageal | 1 | 2000 | 11 | 0.040 |
Why?
|
Endoscopy | 2 | 2021 | 1852 | 0.040 |
Why?
|
Rhabdomyosarcoma | 1 | 2003 | 354 | 0.040 |
Why?
|
Glycolysis | 1 | 2024 | 838 | 0.040 |
Why?
|
Hypopharynx | 1 | 2000 | 53 | 0.040 |
Why?
|
Cell Movement | 1 | 2012 | 5190 | 0.040 |
Why?
|
Child | 6 | 2017 | 80510 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2024 | 797 | 0.040 |
Why?
|
Cell Survival | 2 | 2009 | 5746 | 0.040 |
Why?
|
Radius | 1 | 2023 | 440 | 0.040 |
Why?
|
Carcinoma in Situ | 1 | 2005 | 777 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2003 | 552 | 0.040 |
Why?
|
Mucocele | 1 | 2000 | 51 | 0.040 |
Why?
|
Comorbidity | 3 | 2019 | 10572 | 0.040 |
Why?
|
Linear Models | 2 | 2019 | 5877 | 0.040 |
Why?
|
Epidermal Cyst | 1 | 2000 | 63 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2008 | 2207 | 0.040 |
Why?
|
Carcinoma | 3 | 2012 | 2313 | 0.040 |
Why?
|
Pharyngeal Diseases | 1 | 2000 | 134 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2017 | 18972 | 0.040 |
Why?
|
Adenolymphoma | 1 | 1999 | 11 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1146 | 0.040 |
Why?
|
Random Allocation | 1 | 2003 | 2394 | 0.040 |
Why?
|
Orbital Fractures | 1 | 2000 | 108 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2000 | 334 | 0.040 |
Why?
|
Suture Techniques | 1 | 2004 | 774 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2004 | 2126 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2011 | 2179 | 0.040 |
Why?
|
Radial Artery | 1 | 2000 | 189 | 0.040 |
Why?
|
Arkansas | 1 | 2018 | 59 | 0.040 |
Why?
|
Eye, Artificial | 1 | 1998 | 18 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2022 | 370 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11506 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10389 | 0.040 |
Why?
|
Poverty | 2 | 2020 | 2714 | 0.040 |
Why?
|
Chordoma | 1 | 2001 | 343 | 0.040 |
Why?
|
Heparin | 1 | 2005 | 1632 | 0.040 |
Why?
|
Chronic Disease | 3 | 2004 | 9355 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2017 | 6111 | 0.040 |
Why?
|
Gastrostomy | 1 | 2000 | 327 | 0.040 |
Why?
|
History, 21st Century | 1 | 2004 | 1573 | 0.040 |
Why?
|
Intraoperative Complications | 1 | 2004 | 1170 | 0.030 |
Why?
|
Hemoglobin A | 1 | 1997 | 84 | 0.030 |
Why?
|
Photosensitizing Agents | 1 | 2021 | 625 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10262 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1233 | 0.030 |
Why?
|
Oroantral Fistula | 1 | 1996 | 7 | 0.030 |
Why?
|
Patient Compliance | 2 | 2018 | 2694 | 0.030 |
Why?
|
Oral Hemorrhage | 1 | 1996 | 24 | 0.030 |
Why?
|
Medically Underserved Area | 1 | 2019 | 267 | 0.030 |
Why?
|
Osseointegration | 1 | 1998 | 269 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5019 | 0.030 |
Why?
|
Esthetics | 1 | 1998 | 327 | 0.030 |
Why?
|
Mediastinitis | 1 | 1996 | 49 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2004 | 1304 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2016 | 163 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1627 | 0.030 |
Why?
|
History, 20th Century | 1 | 2004 | 2761 | 0.030 |
Why?
|
Lymphatic Irradiation | 1 | 2016 | 110 | 0.030 |
Why?
|
Radiation Injuries | 2 | 2016 | 1181 | 0.030 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 1996 | 113 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2005 | 2082 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 6220 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 267 | 0.030 |
Why?
|
Carcinogens | 1 | 2017 | 451 | 0.030 |
Why?
|
Cell Communication | 2 | 2013 | 1659 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15887 | 0.030 |
Why?
|
Speech, Alaryngeal | 1 | 1995 | 32 | 0.030 |
Why?
|
Radiation Injuries, Experimental | 1 | 2015 | 88 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1997 | 1006 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2000 | 1263 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2020 | 912 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2036 | 0.030 |
Why?
|
Cell Cycle | 2 | 2013 | 2918 | 0.030 |
Why?
|
Adenovirus E1B Proteins | 1 | 2014 | 15 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 89 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2012 | 2943 | 0.030 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2014 | 58 | 0.030 |
Why?
|
Endocrinology | 1 | 2020 | 442 | 0.030 |
Why?
|
Veins | 1 | 1999 | 769 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 1995 | 281 | 0.030 |
Why?
|
Relative Biological Effectiveness | 1 | 2016 | 299 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2015 | 5880 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6261 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2018 | 2011 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2000 | 803 | 0.030 |
Why?
|
Mesocricetus | 1 | 2014 | 256 | 0.030 |
Why?
|
Cranial Nerve Diseases | 1 | 1994 | 111 | 0.030 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2015 | 256 | 0.030 |
Why?
|
Medical Illustration | 1 | 1994 | 134 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 592 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1617 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2014 | 14445 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2015 | 369 | 0.030 |
Why?
|
Eating | 1 | 2000 | 1539 | 0.030 |
Why?
|
Cranial Fossa, Posterior | 2 | 2006 | 134 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1593 | 0.030 |
Why?
|
Aspirin | 1 | 2005 | 3135 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2001 | 3794 | 0.030 |
Why?
|
Bone Transplantation | 1 | 1998 | 920 | 0.030 |
Why?
|
Sequence Homology | 1 | 2013 | 197 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2021 | 1532 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1819 | 0.030 |
Why?
|
Marijuana Smoking | 1 | 2016 | 260 | 0.030 |
Why?
|
Travel | 1 | 2019 | 806 | 0.030 |
Why?
|
Universities | 1 | 2018 | 1004 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 1998 | 1195 | 0.030 |
Why?
|
Erythropoietin | 1 | 1997 | 716 | 0.030 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 783 | 0.030 |
Why?
|
Wound Healing | 1 | 2003 | 2793 | 0.030 |
Why?
|
Neuroectodermal Tumors | 1 | 2012 | 23 | 0.020 |
Why?
|
Genetic Vectors | 2 | 2014 | 3404 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 1605 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2015 | 576 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 1997 | 568 | 0.020 |
Why?
|
Marijuana Abuse | 1 | 2016 | 411 | 0.020 |
Why?
|
Caspase 3 | 1 | 2014 | 731 | 0.020 |
Why?
|
Pharynx | 1 | 1994 | 436 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2012 | 11862 | 0.020 |
Why?
|
Drug Costs | 1 | 2020 | 1193 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2015 | 517 | 0.020 |
Why?
|
Immunotherapy | 2 | 2021 | 4752 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 561 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1996 | 665 | 0.020 |
Why?
|
Income | 1 | 2020 | 1874 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 372 | 0.020 |
Why?
|
Thrombosis | 1 | 2005 | 2956 | 0.020 |
Why?
|
Voice Disorders | 1 | 1994 | 286 | 0.020 |
Why?
|
Nasal Cartilages | 1 | 2010 | 16 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2013 | 871 | 0.020 |
Why?
|
Up-Regulation | 2 | 2015 | 4136 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2014 | 1467 | 0.020 |
Why?
|
Etoposide | 1 | 2012 | 636 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2979 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3890 | 0.020 |
Why?
|
Gene Expression | 2 | 2013 | 7583 | 0.020 |
Why?
|
Necrosis | 2 | 2009 | 1613 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 1996 | 1595 | 0.020 |
Why?
|
Suicide, Attempted | 1 | 2018 | 1412 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1993 | 764 | 0.020 |
Why?
|
Anticoagulants | 1 | 2005 | 4863 | 0.020 |
Why?
|
Paranasal Sinuses | 1 | 2012 | 267 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 3137 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2115 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 702 | 0.020 |
Why?
|
Health Care Costs | 1 | 2022 | 3243 | 0.020 |
Why?
|
Ligation | 1 | 2009 | 444 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3909 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2190 | 0.020 |
Why?
|
Students | 1 | 2018 | 1739 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22320 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1997 | 2699 | 0.020 |
Why?
|
Recurrence | 2 | 2000 | 8505 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2009 | 414 | 0.020 |
Why?
|
Dental Implants | 1 | 1996 | 790 | 0.020 |
Why?
|
Bone and Bones | 1 | 1998 | 2554 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2195 | 0.020 |
Why?
|
Ear Canal | 1 | 2007 | 149 | 0.020 |
Why?
|
Neutrons | 1 | 2006 | 78 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 2392 | 0.020 |
Why?
|
Sphenoid Sinus | 1 | 2006 | 101 | 0.020 |
Why?
|
Polymers | 1 | 1993 | 1618 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2538 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2827 | 0.020 |
Why?
|
Neurosurgery | 1 | 1992 | 683 | 0.020 |
Why?
|
Cisplatin | 1 | 2012 | 1656 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2006 | 121 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2427 | 0.020 |
Why?
|
Ear, Middle | 1 | 2007 | 341 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13639 | 0.020 |
Why?
|
Equipment Design | 1 | 1993 | 3487 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 1996 | 2660 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 2447 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5448 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6508 | 0.010 |
Why?
|
Immunotherapy, Adoptive | 1 | 2014 | 1511 | 0.010 |
Why?
|
Skin | 1 | 1998 | 4479 | 0.010 |
Why?
|
Carboplatin | 2 | 1997 | 789 | 0.010 |
Why?
|
Antigens, CD | 1 | 2015 | 4020 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1994 | 1659 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 2423 | 0.010 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2006 | 297 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2005 | 682 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 4961 | 0.010 |
Why?
|
Myofibrils | 1 | 2003 | 143 | 0.010 |
Why?
|
Peptides | 1 | 2015 | 4328 | 0.010 |
Why?
|
Remission Induction | 1 | 2008 | 2409 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 2898 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8602 | 0.010 |
Why?
|
Cathepsin L | 1 | 2001 | 69 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9521 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13402 | 0.010 |
Why?
|
Protons | 1 | 2006 | 1071 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5501 | 0.010 |
Why?
|
Collagenases | 1 | 2001 | 221 | 0.010 |
Why?
|
Sarcoma | 1 | 2012 | 1801 | 0.010 |
Why?
|
Cathepsins | 1 | 2001 | 242 | 0.010 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2001 | 324 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17595 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3593 | 0.010 |
Why?
|
Paclitaxel | 2 | 1997 | 1728 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2003 | 1071 | 0.010 |
Why?
|
Dura Mater | 1 | 2001 | 296 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2001 | 542 | 0.010 |
Why?
|
Glottis | 1 | 2000 | 212 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12402 | 0.010 |
Why?
|
Multigene Family | 1 | 2001 | 1081 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2001 | 1984 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13615 | 0.010 |
Why?
|
Voice Quality | 1 | 2000 | 226 | 0.010 |
Why?
|
Hair | 1 | 2001 | 508 | 0.010 |
Why?
|
Algorithms | 1 | 1998 | 14061 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7425 | 0.010 |
Why?
|
Alopecia | 1 | 2001 | 415 | 0.010 |
Why?
|
Child, Preschool | 2 | 2005 | 42481 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1996 | 425 | 0.010 |
Why?
|
Osteosarcoma | 1 | 2001 | 909 | 0.010 |
Why?
|
Azathioprine | 1 | 1996 | 350 | 0.010 |
Why?
|
Sampling Studies | 1 | 1996 | 610 | 0.010 |
Why?
|
Laryngoscopy | 1 | 2000 | 686 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4563 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5336 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 1997 | 1009 | 0.010 |
Why?
|
Prednisone | 1 | 1996 | 1563 | 0.010 |
Why?
|
Thoracic Neoplasms | 1 | 1993 | 267 | 0.010 |
Why?
|
Mutation | 2 | 2009 | 30187 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1997 | 4850 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2001 | 3682 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2000 | 3479 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6489 | 0.000 |
Why?
|
Software | 1 | 2001 | 4457 | 0.000 |
Why?
|
Glucocorticoids | 1 | 1996 | 2132 | 0.000 |
Why?
|
Anti-Inflammatory Agents | 1 | 1996 | 1805 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9439 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1992 | 36543 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1996 | 4526 | 0.000 |
Why?
|
Life Style | 1 | 1996 | 3929 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 1996 | 4208 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1996 | 12969 | 0.000 |
Why?
|